Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 4
1976 36
1977 26
1978 69
1979 131
1980 87
1981 88
1982 112
1983 124
1984 84
1985 89
1986 78
1987 102
1988 106
1989 104
1990 91
1991 87
1992 62
1993 65
1994 44
1995 35
1996 25
1997 20
1998 28
1999 31
2000 35
2001 26
2002 26
2003 21
2004 31
2005 26
2006 36
2007 31
2008 48
2009 44
2010 42
2011 52
2012 53
2013 46
2014 54
2015 60
2016 57
2017 58
2018 50
2019 60
2020 67
2021 56
2022 66
2023 70
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

2,749 results

Results by year

Filters applied: . Clear all
Page 1
Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
MacCarthy EP, Bloomfield SS. MacCarthy EP, et al. Pharmacotherapy. 1983 Jul-Aug;3(4):193-219. doi: 10.1002/j.1875-9114.1983.tb03252.x. Pharmacotherapy. 1983. PMID: 6310529 Review.
Labetalol is a combined alpha- and beta-adrenoceptor blocking agent for oral and intravenous use in the treatment of hypertension. ...Labetalol administered alone or with a diuretic is often effective when other antihypertensive regimens have failed. ...
Labetalol is a combined alpha- and beta-adrenoceptor blocking agent for oral and intravenous use in the treatment of hypertension. .. …
Labetalol.
Carter BL. Carter BL. Drug Intell Clin Pharm. 1983 Oct;17(10):704-12. Drug Intell Clin Pharm. 1983. PMID: 6354658 Review.
Labetalol is a competitive antagonist of alpha 1-, beta 1-, and beta 2-adrenergic receptors. ...Reductions in heart rate are less pronounced with labetalol as compared with propranolol. Labetalol produces rapid reductions in blood pressure when administered i …
Labetalol is a competitive antagonist of alpha 1-, beta 1-, and beta 2-adrenergic receptors. ...Reductions in heart rate are less pro …
Metabolic Activation and Cytotoxicity of Labetalol Hydrochloride Mediated by Sulfotransferases.
Yang L, Xin L, Shi J, Li W, Tian M, Hu Z, Peng Y, Zheng J. Yang L, et al. Chem Res Toxicol. 2021 Jun 21;34(6):1612-1618. doi: 10.1021/acs.chemrestox.1c00060. Epub 2021 Apr 19. Chem Res Toxicol. 2021. PMID: 33872499
Labetalol hydrochloride (LHCl), an alpha- and beta-adrenoreceptor blocker, is widely used for the treatment of hypertension as well as angina pectoris. ...
Labetalol hydrochloride (LHCl), an alpha- and beta-adrenoreceptor blocker, is widely used for the treatment of hypertension as …
Labetalol in hypertension.
[No authors listed] [No authors listed] Lancet. 1977 Apr 23;1(8017):890-1. Lancet. 1977. PMID: 67294 No abstract available.
Clinical pharmacology of labetalol.
Richards DA, Prichard BN. Richards DA, et al. Br J Clin Pharmacol. 1979;8(Suppl 2):89S-93S. Br J Clin Pharmacol. 1979. PMID: 43165 Free PMC article. Review.
1 The clinical pharmacology of labetalol has been evaluated using pharmacological and physiological test methods. 2 Labetalol displaces the log dose-response curves to the right of isoprenaline-induced increases in heart rate, cardiac output and decreases in diastol …
1 The clinical pharmacology of labetalol has been evaluated using pharmacological and physiological test methods. 2 Labetalol …
Electrochemical Quantitative Assessment of Labetalol Hydrochloride in Pure Form and Combined Pharmaceutical Formulations.
Salem MY, Hassan NY, Fayez YM, Mohamed SAE, Ali ES. Salem MY, et al. Acta Chim Slov. 2020 Jun;67(2):396-402. Acta Chim Slov. 2020. PMID: 33855568
This work describes how to utilize the electrochemical technique to determine labetalol hydrochloride (Lab) in pure form and combined pharmaceutical formulation for quality control purposes. ...
This work describes how to utilize the electrochemical technique to determine labetalol hydrochloride (Lab) in pure form and c …
Does Labetalol Trigger False Positive Drug Testing Results?
Bithi N, Merrigan SD, McMillin GA. Bithi N, et al. J Addict Med. 2023 May-Jun 01;17(3):e209-e210. doi: 10.1097/ADM.0000000000001117. Epub 2022 Nov 30. J Addict Med. 2023. PMID: 37267192
OBJECTIVES: Labetalol, an alpha- and beta-adrenergic antagonist used to treat hypertension in pregnancy has been blamed for causing false-positive amphetamine and methamphetamine results. ...METHODS: Residual drug-free specimens were pooled. Labetalol hydrochlori …
OBJECTIVES: Labetalol, an alpha- and beta-adrenergic antagonist used to treat hypertension in pregnancy has been blamed for causing f …
Labetalol hepatotoxicity.
[No authors listed] [No authors listed] Ann Intern Med. 1991 Feb 15;114(4):341. doi: 10.7326/0003-4819-114-4-341. Ann Intern Med. 1991. PMID: 2018583 No abstract available.
Derivatization of labetalol hydrochloride for its spectrofluorimetric and spectrophotometric determination inhuman plasma: Application to stability study.
Omar MA, Derayea SM, Abdel-Lateef MA, El Hamd MA. Omar MA, et al. Spectrochim Acta A Mol Biomol Spectrosc. 2018 Feb 5;190:457-463. doi: 10.1016/j.saa.2017.09.059. Epub 2017 Sep 22. Spectrochim Acta A Mol Biomol Spectrosc. 2018. PMID: 28961530
Two simple, selective and accurate methods were developed for the determination of Labetalol hydrochloride in pure form and pharmaceutical tablets. Both methods are based on derivatization of the studied drug with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole (NBDCl) in a …
Two simple, selective and accurate methods were developed for the determination of Labetalol hydrochloride in pure form and ph …
Distinct outcomes of labetalol exposed infants: case reports and systematic review.
Yang X, Hui L, Long H, Zou L. Yang X, et al. J Matern Fetal Neonatal Med. 2021 Jun;34(12):2012-2018. doi: 10.1080/14767058.2019.1651270. Epub 2019 Sep 11. J Matern Fetal Neonatal Med. 2021. PMID: 31510808 Review.
A systematic literature review was carried out followed by a retrospective analysis on neonatal labetalol withdrawal effects. RESULTS: It was discovered that labetalol withdrawal effects initially cause various degrees of hypotension, hypoglycemia, and bradycardia a …
A systematic literature review was carried out followed by a retrospective analysis on neonatal labetalol withdrawal effects. RESULTS …
2,749 results